CN1030245C - 肝泰宝胶囊及其生产工艺 - Google Patents

肝泰宝胶囊及其生产工艺 Download PDF

Info

Publication number
CN1030245C
CN1030245C CN 93117585 CN93117585A CN1030245C CN 1030245 C CN1030245 C CN 1030245C CN 93117585 CN93117585 CN 93117585 CN 93117585 A CN93117585 A CN 93117585A CN 1030245 C CN1030245 C CN 1030245C
Authority
CN
China
Prior art keywords
radix
hepatitis
medicine
hours
schisandrae chinensis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 93117585
Other languages
English (en)
Other versions
CN1089503A (zh
Inventor
肖才松
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hunan Kang Medicine Management Group Co Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 93117585 priority Critical patent/CN1030245C/zh
Publication of CN1089503A publication Critical patent/CN1089503A/zh
Application granted granted Critical
Publication of CN1030245C publication Critical patent/CN1030245C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

本发明涉及一种治疗急、慢性乙型肝炎及乙肝病毒携带者的纯中药制剂及其生产工艺。它的组成成分及各成分的比例(重量比)为:郁金7.80%、田三七3.91%、姜黄3.91%、益母草11.72%、当归3.91%、黄芪15.63%、大黄6.25%、黄芩7.80%、蜈蚣3.91%、大枣3.91%、淮山11.72%、五味子3.91%、菟丝子15.62%。该药品能化瘀通络,搜风解毒,舒肝养胃,对急、慢性乙型肝炎及乙肝病毒持续携带者有良好的治疗效果,且药用安全,无毒副反应。

Description

本发明涉及一种治疗急、慢性乙型肝炎及乙肝病毒携带者的纯中药制剂及其生产工艺。
乙肝病毒的感染,是当前一项严重的社会卫生问题。目前,治疗乙肝病的药物较多,它们对改善临床症状、体征、促进肝功能的恢复起到了一定的作用,但对抗乙肝病毒,抑制乙肝病毒复制的药效作用尚未得到肯定。现有某些西药制品类,如“无环鸟苷”、“干扰素”等,虽有抗乙肝病毒的作用,但因毒副作用多,甚至反而使部分肝功能恶化,且疗程长,价格昂贵,因此,难以在临床推广应用。
本发明的目的在于提供一种保肝降酶、抗乙肝病毒、抑制乙肝病毒去氧核糖核酸的作用,且能诱生人白细胞产生干扰素的肝泰宝胶囊及其生产工艺。
本发明的组成成分及各成成分的比例(重量比)为:郁金7.80%、田三七3.91%、姜黄3.91%、益母草11.72%、当归3.91%、黄芪15.63%、大黄6.25%、黄芩7.80%、蜈蚣3.91%、大枣3.91%、淮山11.72%、五味子3.91%、菟丝子15.62%。其生产工艺为:(1)取五味子用水浸泡过夜(12小时),捣烂,去皮,干燥后得种仁,碾碎种仁后置入回流罐中,加90%乙醇回流,78±1℃,原料与乙醇比为1∶4,然后用原料与乙醇比1∶2再回流两次,合并浸液,回收乙醇,烘干得五味子浸膏粉。(2)按配方比例取郁金、田三七、姜黄、益母草、当归、黄芪、黄芩、蜈蚣、大枣、淮山、菟丝子混合,按药物的总量加入8倍的水煎1.5小时,然后加入用50度谷、米酒浸润6小时后烤干之大黄,继续煎煮半小时,滤过后,再按药物的总量加6倍的水煎2小时,滤过,弃药渣,合并滤液;滤液浓缩至热测比重为1.20,在80℃以下干燥得余药浸膏粉。(3) 将五味子浸膏粉与余药浸膏粉合并,粉碎,充分搅拌,制粒,消毒,抽检,灌装即制得合格药品。
实施例:(1)取500g五味子用水浸泡过夜(12小时),捣烂,去皮,干燥后得种仁,碾碎种仁后置入回流罐中,加90%乙醇2000ml回流,78℃,然后再用90%乙醇1000ml再回流两次,合并浸液,回收乙醇,烘干得60g五味子浸膏粉。
(2)取1000g郁金、500g田三七、500g姜黄、1500g益母草、500g当归、2000g黄芪、1000g黄芩、500g蜈蚣、500g大枣、1500g淮山、2000g菟丝子混合,加入92kg水煎1.5小时,然后加入用50度谷、米酒浸润6小时后烤干之大黄800g,继续煎煮半小时,滤过后,再加69kg水煎2小时,滤过,弃药渣,合并滤液;滤液浓缩至热测比重为1.20,在80℃以下干燥得12300g余药浸膏粉。
(3)将60g五味子浸膏粉与12300g余药浸膏粉合并,粉碎,充分搅拌,制粒,消毒,抽检,灌装,制得每粒药0.3g之胶囊。
本发明不限于上述一个实施例。
本发明能化瘀通络,搜风解毒,舒肝养胃,用于急、慢性乙肝瘀血阻络,肝郁脾困、肝肾阴虚证及HBsAg携带者的治疗。该药品对急、慢性乙型肝炎及乙肝病毒持续携带者有良好的治疗效果,尤其对乙肝表面抗原的转阴作用明显,对于阻断肝病的慢性化发展,控制肝硬化、肝癌的发病率起到一定的防治作用,且药用安全,无毒副反应。

Claims (2)

1、一种肝泰宝胶囊,其原料特征为(重量比):郁金7.80%、田三七3.91%、姜黄3.91%、益母草11.72%、当归3.91%、黄芪15.63%、大黄6.25%、黄芩7.80%、蜈蚣3.91%、大枣3.91%、淮山11.72%、五味子3.91%、菟丝子15.62%。
2、一种肝泰宝胶囊的生产工艺,其特征为:
A.取3.91%五味子用水浸泡过夜(12小时),去皮,干燥后得种仁,碾碎种仁后置入回流罐中,加90%乙醇回流,78±1℃,原料与乙醇比为1∶4,然后用原料与乙醇比1∶2再回流两次,合并浸液,回收乙醇,烘干得五味子浸膏粉;
B.取7.80%郁金、3.91%田三七、3.91%姜黄、11.72%益母草、3.91%当归、15.63%黄芪、7.80%黄芩、3.91%蜈蚣、3.91%大枣、11.72%淮山、15.62%菟丝子混合,按药物的总量加入8倍的水煎1.5小时,然后加入用50度谷、米酒浸润6小时后烤干之6.25%大黄,继续煎煮半小时,滤过后,再按药物的总量加6倍的水煎2小时,滤过,弃药渣,合并滤液;滤液浓缩至热测比重为1.20,在80℃以下干燥得余药浸膏粉;
C.将五味子浸膏粉与余药浸膏粉合并,粉碎,充分搅拌,制粒,消毒,抽检,灌装即制得合格药品。
CN 93117585 1993-09-24 1993-09-24 肝泰宝胶囊及其生产工艺 Expired - Fee Related CN1030245C (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 93117585 CN1030245C (zh) 1993-09-24 1993-09-24 肝泰宝胶囊及其生产工艺

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 93117585 CN1030245C (zh) 1993-09-24 1993-09-24 肝泰宝胶囊及其生产工艺

Publications (2)

Publication Number Publication Date
CN1089503A CN1089503A (zh) 1994-07-20
CN1030245C true CN1030245C (zh) 1995-11-15

Family

ID=4992097

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 93117585 Expired - Fee Related CN1030245C (zh) 1993-09-24 1993-09-24 肝泰宝胶囊及其生产工艺

Country Status (1)

Country Link
CN (1) CN1030245C (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1058404C (zh) * 1996-02-27 2000-11-15 徐明龙 一种治疗乙肝的药物
CN1066951C (zh) * 1997-09-04 2001-06-13 田丽华 一种治疗结核病和肝炎的中药
CN101612363B (zh) * 2009-08-07 2014-08-06 张喜田 升高白蛋白的天然药物制剂

Also Published As

Publication number Publication date
CN1089503A (zh) 1994-07-20

Similar Documents

Publication Publication Date Title
ZA200302647B (en) Novel medicinal herbal composition for treating liver diseases.
CN1172674A (zh) 治疗皮肤病的中药组合物
CN1081067C (zh) 治疗肝炎、胆管炎、胰腺炎、肝硬化的中药配方
US9789153B2 (en) Composition for preventing cancer and treating cancer and intensifying the effects of other anticancer drugs
CN1178675C (zh) 一种治疗肝、胆疾病的药物
CN103223069A (zh) 一种治疗肝炎的中药组合物
CN1030245C (zh) 肝泰宝胶囊及其生产工艺
CN101361789B (zh) 一种防治肿瘤放疗后肺损伤的中药制剂
CN1063954C (zh) 一种治疗乙肝的中成药
CN1083370A (zh) 银翘解毒口服液的剂型及工艺流程
CN100534506C (zh) 一种治疗病毒性肝炎的中药组合物
CN1063655C (zh) 治疗乙型肝炎的纯中药浓缩胶囊
CN1063088C (zh) 肝胆治
CN1176113A (zh) 复方华蟾素
CN101085088A (zh) 治疗前列腺增生的中药方剂
CN1240415C (zh) 治疗过敏性紫癜的药片
CN1079252C (zh) 一种治疗癌肿的药物
CN1144595C (zh) 抗癌胶囊及其制备方法
CN1814250B (zh) 一种治疗肝硬化腹水的中药组合物及其制备方法
CN1286483C (zh) 益肝化纤排毒中药丸
CN1078897A (zh) “乙肝康”中药制剂及其制备工艺
CN100518800C (zh) 一种用于治疗乙型肝炎的药物组合物
CN1102591A (zh) 三苗复方合剂及其配方
CN1098294A (zh) 慢肝宁
CN1086129C (zh) 一种治疗肝炎的药物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: CHANGSHA KANGERJIA PHARMACY GROUP CO.,LTD.

Free format text: FORMER OWNER: XIAO CAISONG

Effective date: 20091113

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20091113

Address after: No. 198 west slope, Changsha, Hunan, Tongzi

Patentee after: Changsha kaang'er Pharmaceutical Group Co., Ltd.

Address before: Room two, 701, three building, three street, Ruyi garden, Luoxi Town, Guangzhou, Guangdong, Panyu

Patentee before: Xiao Caisong

ASS Succession or assignment of patent right

Owner name: HU NAN KANGERJIA PHARMACEUTICAL MANAGEMENT GROUP C

Free format text: FORMER OWNER: CHANGSHA KANGERJIA PHARMACEUTICAL GROUP CO., LTD.

Effective date: 20101119

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20101119

Address after: 410205 No. 198 west slope road, Changsha, Hunan, Tongzi

Patentee after: Hunan Kang Medicine Management Group Co., Ltd.

Address before: 410205 No. 198 west slope road, Changsha, Hunan, Tongzi

Patentee before: Changsha kaang'er Pharmaceutical Group Co., Ltd.

C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 19951115

Termination date: 20120924